Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins.

OBJECTIVES To define the sonographic characteristics of local cancer recurrence after radical prostatectomy. METHODS in 114 patients with an elevated prostate-specific antigen (PSA) and negative bone scan, 156 ultrasound-guided prostate fossa biopsies were carried out. RESULTS in 53.5%, biopsy proved local recurrence. More than one ultrasound-guided biopsy session was required to make the diagnosis in 33% of patients. Local recurrence was seen on ultrasound at the anastomotic site (66%), the bladder neck (16%), and posterior to the trigone (13%). in 5% of patients there was a normal-appearing anastomotic site. Transrectal ultrasound was greater than 90% sensitive in detecting local recurrence, but lacked specificity. Examination of the radical prostatectomy specimens in patients with local recurrence showed positive surgical margins in 66% and organ-confined disease in 20%. CONCLUSIONS Transrectal ultrasonography is a useful adjunct to PSA and digital rectal examination in the detection of local recurrences following radical prostatectomy.

[1]  J. Adolfsson,et al.  'Local recurrence' and 'disease-free survival'. Doubtful parameters when comparing non-randomized studies of prostate cancer. , 1991, Scandinavian journal of urology and nephrology. Supplementum.

[2]  D. McCullough,et al.  Radical pelvic surgery for locally extensive carcinoma of the prostate. , 1972, The Journal of urology.

[3]  Oesterling Je,et al.  Patient evaluation if prostate-specific antigen becomes elevated following radical prostatectomy or radiation therapy. , 1994 .

[4]  A W Partin,et al.  Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. , 1993, The Urologic clinics of North America.

[5]  A W Partin,et al.  Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup. , 1993, The Journal of urology.

[6]  P. Scardino,et al.  Frequency and location of extracapsular extension and positive surgical margins in radical prostatectomy specimens. , 1992, The Journal of urology.

[7]  T. Fleming,et al.  Course of localized adenocarcinoma of the prostate treated by radical prostatectomy , 1983, The Prostate.

[8]  S. Goldenberg,et al.  Sonographic characteristics of the urethrovesical anastomosis in the early post-radical prostatectomy patient. , 1992, The Journal of urology.

[9]  A. Partin,et al.  Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases. , 1994, Urology.

[10]  S. Schild,et al.  Radiotherapy for isolated increases in serum prostate-specific antigen levels after radical prostatectomy. , 1994, Mayo Clinic proceedings.

[11]  J. Dekernion,et al.  Detection of local recurrence after radical prostatectomy by prostate specific antigen and transrectal ultrasound. , 1992, The Journal of urology.

[12]  R. Vessella,et al.  The value of serum prostate specific antigen determinations before and after radical prostatectomy. , 1989, The Journal of urology.

[13]  D. Kapoor,et al.  Value of transrectal ultrasound in identifying local disease after radical prostatectomy. , 1993, Urology.

[14]  F. Freiha,et al.  External beam radiation salvage for residual or recurrent local tumor following radical prostatectomy. , 1984, The Journal of urology.

[15]  M. Anscher,et al.  Postoperative Radiotherapy for Patients with Carcinoma of the Prostate Undergoing Radical Prostatectomy with Positive Surgical Margins, Seminal Vesicle Involvement and/or Penetration Through the Capsule , 1987 .

[16]  P. Walsh,et al.  Cancer control following anatomical radical prostatectomy: an interim report. , 1991, The Journal of urology.

[17]  Z. Petrovich,et al.  Radical retropubic prostatectomy and postoperative adjuvant radiation for pathological stage C (PcN0) prostate cancer from 1976 to 1989: intermediate findings. , 1993, The Journal of urology.

[18]  P. Lange,et al.  Prostate specific antigen and local recurrence after radical prostatectomy. , 1990, The Journal of urology.

[19]  R. Vessella,et al.  The enhanced detection of persistent disease after prostatectomy with a new prostate specific antigen immunoassay. , 1993, The Journal of urology.

[20]  A. Zietman,et al.  Residual disease after radical surgery or radiation therapy for prostate cancer. Clinical significance and therapeutic implications , 1993, Cancer.

[21]  J. Moul,et al.  Postoperative radiotherapy of the prostate for patients undergoing radical prostatectomy with positive margins, seminal vesicle involvement and/or penetration through the capsule. , 1990, The Journal of urology.

[22]  N. Olson,et al.  Analysis of risk factors associated with prostate cancer extension to the surgical margin and pelvic node metastasis at radical prostatectomy. , 1993, The Journal of urology.

[23]  P. Carroll,et al.  The value of prostate specific antigen and transrectal ultrasound guided biopsy in detecting prostatic fossa recurrences following radical prostatectomy. , 1993, The Journal of urology.

[24]  Galina Pizov,et al.  Correlation of pathologic findings with progression after radical retropubic prostatectomy , 1993, Cancer.